LGALS1 and neoplasm: Inhibition of LGALS1 has been shown to reduce the metastatic capability of the MDA-MB-231 breast cancer cell line [68], and expression of LGALS1 can affect the metastasis of breast cancer, supporting our hypothesis that targeting LGALS1 could obstruct tumor progression.